Menu

A New Pill Could Reduce the Risk of Having a Second Stroke
📰

A New Pill Could Reduce the Risk of Having a Second Stroke

#time#blood#stroke#strokes#says
Reading 0:00
15s threshold

On November 9, the U.S. Food and Drug Administration (FDA) approved a new type of medication to reduce the risk of strokes in certain populations.

Asundexian, which will be sold under the brand name Sunharbo, is a daily pill that is the first to target a specific factor in the blood-clotting process that can contribute to stroke. In a study submitted to the FDA by Bayer, researchers found that the drug, when combined with an antiplatelet therapy such as aspirin, reduced the risk of an additional stroke by 26% in just over a year compared to people who received placebo and the antiplatelet therapy. The drug is approved for people who have recently had an ischemic stroke, which occur when clots block blood flow to the brain, or a transient ischemic attack caused by a temporary blockage of blood flow to the brain that doesn’t cause permanent damage.

“The data is quite robust, and the feedback from the international stroke community is positive,” says Dr.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.